Anika reports inducement grants under nasdaq listing rule 5635(c)(4)

Bedford, mass., may 13, 2022 (globe newswire) -- anika therapeutics, inc. (nasdaq: anik), a global joint preservation company in early intervention orthopedics, today announced that on may 2, 2022, anika granted non-statutory stock options (“options”) covering an aggregate of 13,091 shares of common stock at a per share exercise price of $21.61, which equaled the closing price of common stock on the nasdaq global select market (“closing price”) on the grant date, 16,113 options at a per share exercise price of $23.77, which equaled 110% of the closing price on the grant date, and restricted stock units ( “rsus”) covering an aggregate of 20,818 shares of common stock to 5 newly hired non-executive employees. each grant was made pursuant to the anika therapeutics, inc. 2021 inducement plan, was approved by the compensation committee of the board of directors pursuant to a delegation of authority by the board of directors, and, in accordance with nasdaq listing rule 5635(c)(4), was made as a material inducement to the grantee's acceptance of employment with anika as a component of the grantee's employment compensation.
ANIK Ratings Summary
ANIK Quant Ranking